-
Je něco špatně v tomto záznamu ?
MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis
Nachtigal P, Pospisilova N, Pospechova K, Jamborova G, Kopecky M, Jaynes R, Briestensky J, Santar I, Smahelova A, Solichova D, Zdansky P, Semecky V
Jazyk angličtina Země Velká Británie
- MeSH
- antiflogistika farmakologie terapeutické užití MeSH
- aplikace orální MeSH
- apolipoproteiny E genetika nedostatek MeSH
- ateroskleróza farmakoterapie MeSH
- celulosa oxidovaná farmakologie terapeutické užití MeSH
- cévní buněčněadhezivní molekula-1 metabolismus MeSH
- cévní endotel metabolismus patologie účinky léků MeSH
- dieta MeSH
- financování organizované MeSH
- hyperlipidemie farmakoterapie MeSH
- kyseliny heptylové farmakologie terapeutické užití MeSH
- lipoproteiny krev MeSH
- mezibuněčná adhezivní molekula-1 metabolismus MeSH
- modely nemocí na zvířatech MeSH
- myši knockoutované MeSH
- myši MeSH
- pyrroly farmakologie terapeutické užití MeSH
- simvastatin farmakologie MeSH
- triglyceridy krev MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
Members of the immunoglobulin superfamily of endothelial adhesion molecules, vascular cell adhesion molecule (VCAM-1) and intercellular cell adhesion molecule (ICAM- 1), strongly participate in leukocyte adhesion to the endothelium and play an important role in all stages of atherogenesis. The aim of this study was to detect and quantify the changes of endothelial expression of VCAM-1, and ICAM-1 in the vessel wall after the short-term administration of simvastatin, atorvastatin, and micro dispersed derivatives of oxidised cellulose (MDOC) in apolipoprotein-E-deficient (apoE(-/-)) mice atherosclerotic model. Hyperlipidemic apoE(-/-) mice (n = 32) received normal chow diet or diet containing simvastatin or atorvastatin 10 mg/kg/day or MDOC 50 mg/kg/day. Total cholesterol, VLDL, LDL, HDL and TAG were measured and the endothelial expression of VCAM-1 and ICAM-1 was visualized and quantified by means of immunohistochemistry and stereology, respectively. Total cholesterol levels was insignificantly lowered only in MDOC treated mice but not in mice treated with statins. ICAM-1 endothelial expression was not affected by neither simvastatin nor MDOC treatment. However, significant diminution of VCAM-1 endothelial expression was observed in both atorvastatin and MDOC treated mice. These results provide new information of potential hypolipidemic substance MDOC and its potential anti-inflammatory effects. Furthermore, we have confirmed anti-inflammatory effects of atorvastatin independent of plasma cholesterol lowering. Thus, the results of this study show potential benefit of both MDOC and atorvastatin treatment in apoE(-/-) mouse model of atherosclerosis suggesting their possible combination might be of interest.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07520492
- 003
- CZ-PrNML
- 005
- 20111210131139.0
- 008
- 090402s2006 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Nachtigall, Petr, $d 1963- $7 xx0033674
- 245 10
- $a MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis / $c Nachtigal P, Pospisilova N, Pospechova K, Jamborova G, Kopecky M, Jaynes R, Briestensky J, Santar I, Smahelova A, Solichova D, Zdansky P, Semecky V
- 314 __
- $a Department of Biological and Medical Sciences, Faculty of Pharmacy, Charles University Hradec Kralove, Heyrovskeho 1203, Hradec Kralove, 50005 Czech Republic. nachti@faf.cuni.cz
- 520 9_
- $a Members of the immunoglobulin superfamily of endothelial adhesion molecules, vascular cell adhesion molecule (VCAM-1) and intercellular cell adhesion molecule (ICAM- 1), strongly participate in leukocyte adhesion to the endothelium and play an important role in all stages of atherogenesis. The aim of this study was to detect and quantify the changes of endothelial expression of VCAM-1, and ICAM-1 in the vessel wall after the short-term administration of simvastatin, atorvastatin, and micro dispersed derivatives of oxidised cellulose (MDOC) in apolipoprotein-E-deficient (apoE(-/-)) mice atherosclerotic model. Hyperlipidemic apoE(-/-) mice (n = 32) received normal chow diet or diet containing simvastatin or atorvastatin 10 mg/kg/day or MDOC 50 mg/kg/day. Total cholesterol, VLDL, LDL, HDL and TAG were measured and the endothelial expression of VCAM-1 and ICAM-1 was visualized and quantified by means of immunohistochemistry and stereology, respectively. Total cholesterol levels was insignificantly lowered only in MDOC treated mice but not in mice treated with statins. ICAM-1 endothelial expression was not affected by neither simvastatin nor MDOC treatment. However, significant diminution of VCAM-1 endothelial expression was observed in both atorvastatin and MDOC treated mice. These results provide new information of potential hypolipidemic substance MDOC and its potential anti-inflammatory effects. Furthermore, we have confirmed anti-inflammatory effects of atorvastatin independent of plasma cholesterol lowering. Thus, the results of this study show potential benefit of both MDOC and atorvastatin treatment in apoE(-/-) mouse model of atherosclerosis suggesting their possible combination might be of interest.
- 650 _2
- $a aplikace orální $7 D000284
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antiflogistika $x farmakologie $x terapeutické užití $7 D000893
- 650 _2
- $a apolipoproteiny E $x genetika $x nedostatek $7 D001057
- 650 _2
- $a ateroskleróza $x farmakoterapie $7 D050197
- 650 _2
- $a celulosa oxidovaná $x farmakologie $x terapeutické užití $7 D002483
- 650 _2
- $a dieta $7 D004032
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a cévní endotel $x metabolismus $x patologie $x účinky léků $7 D004730
- 650 _2
- $a kyseliny heptylové $x farmakologie $x terapeutické užití $7 D006538
- 650 _2
- $a hyperlipidemie $x farmakoterapie $7 D006949
- 650 _2
- $a mezibuněčná adhezivní molekula-1 $x metabolismus $7 D018799
- 650 _2
- $a lipoproteiny $x krev $7 D008074
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a pyrroly $x farmakologie $x terapeutické užití $7 D011758
- 650 _2
- $a simvastatin $x farmakologie $7 D019821
- 650 _2
- $a triglyceridy $x krev $7 D014280
- 650 _2
- $a cévní buněčněadhezivní molekula-1 $x metabolismus $7 D019010
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Pospíšilová, Naďa $7 xx0095413
- 700 1_
- $a Pospěchová, Kateřina $7 xx0104147
- 700 1_
- $a Jamborová, Gabriela. $7 _BN003298
- 700 1_
- $a Kopecký, Martin, $d 1977 březen 23.- $7 xx0099044
- 700 1_
- $a Jaynes, Robert
- 700 1_
- $a Briestenský, Jiří $7 xx0103976
- 700 1_
- $a Santar, Ivan $7 xx0099429
- 700 1_
- $a Šmahelová, Alena, $d 1952- $7 skuk0001359
- 700 1_
- $a Solichová, Dagmar $7 xx0060526
- 700 1_
- $a Žďánský, Petr, $d 1942- $7 xx0076498
- 700 1_
- $a Semecký, Vladimír, $d 1943- $7 nlk19990073843
- 773 0_
- $w MED00003147 $t Life sciences $g Roč. 78, č. 17 (2006), s. 1983-1989 $x 0024-3205
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090312170439 $b ABA008
- 991 __
- $a 20090717104610 $b ABA008
- 999 __
- $a ok $b bmc $g 638295 $s 491094
- BAS __
- $a 3
- BMC __
- $a 2006 $b 78 $c 17 $d 1983-1989 $i 0024-3205 $m Life sciences $x MED00003147
- LZP __
- $a 2009-B1/vtme